Cut Drug Development Costs from $2.4B to $0.6B with AI

AI-driven drug development could reduce costs from $2.4B to $0.6B per drug and cut time-to-market by 40%. AlphaFold revolutionized protein prediction. Build the AI pharma stack.

The Opportunity

AI-driven drug development could:

• •Reduce costs from $2.4 billion to $0.6 billion per drug (75% reduction)
• •Cut time-to-market by ~40%
• •Save 2-5 years in discovery timelines

Why Now

• •DNA sequencing costs dropped 10^10-fold over 35 years (exceeding Moore's Law)
• •Genome analysis time: from 180 days (2001) to under 10 minutes
• •AlphaFold revolutionized protein structure prediction with "orders-of-magnitude productivity gains"
• •Successive versions predict complex multi-chain protein interactions

What's Needed

• •AI models for target identification
• •Virtual screening and lead optimization
• •Clinical trial design and patient matching
• •Regulatory submission automation
• •Integration with lab automation
• •Biological data infrastructure

The Economics

Cures (vs. chronic treatments) could command higher upfront prices with significantly increased lifetime value. The pharmaceutical economics are being reset.